P2X1 Receptor Inhibition and Soluble CD39 Administration as Novel Approaches to Widen the Cardiovascular Therapeutic Window

Trends in Cardiovascular Medicine

Volumn 19, Issue 1, 2009, Pages 1-5

  Fung, C Y E ^a   Marcus, Aaron J ^b   Broekman, M Johan ^b   Mahaut Smith, Martyn P ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PROTEIN; PURINERGIC P2X1 RECEPTOR; RECOMBINANT SOLUBLE CD39 ANTIGEN; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; DRUG INHIBITION; HEMOSTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS;

ADENOSINE TRIPHOSPHATE; ANTIGENS, CD; APYRASE; ASPIRIN; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; CEREBRAL HEMORRHAGE; CLINICAL TRIALS AS TOPIC; CYCLOOXYGENASE INHIBITORS; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; HUMANS; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PURINERGIC P2; TICLOPIDINE; TREATMENT OUTCOME;

EID: 65649127793     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2009.01.005     Document Type: Review

References (39)

1. 1 and secondary mediators. J Thromb Haemost 1 (2003) 1278-1287
2. Buergler J.M., Maliszewski C.R., Broekman M.J., et al. Effects of solCD39, a novel inhibitor of platelet aggregation, on platelet deposition and aggregation after PTCA in a porcine model. J Thromb Thrombolysis 19 (2005) 115-122
3. Buresly K., Eisenberg M.J., Zhang X., and Pilote L. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med 165 (2005) 784-789
4. Cerbone A.M., Macarone-Palmieri N., Saldalamacchia G., et al. Diabetes, vascular complications and antiplatelet therapy: open problems. Acta Diabetol (2008) (electronic publication Dec 2, 2008)
5. Cooper J.A., Hill S.J., Alexander S.P., Rubin P.C., and Horn E.H. Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets. Br J Clin Pharmacol 40 (1995) 43-50
6. Deaglio S., Dwyer K.M., Gao W., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204 (2007) 1257-1265
7. Dwyer K.M., Robson S.C., Nandurkar H.H., et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 113 (2004) 1440-1446
8. 1 stimulation promotes thrombin receptor-mediated platelet aggregation. J Thromb Haemost 4 (2006) 882-890
9. Farndale R.W. Collagen-induced platelet activation. Blood Cells Mol Dis 36 (2006) 162-165
10. 2+ responses of human platelets. Thromb Haemost 94 (2005) 37-40
11. 2+ in the human platelet. J Thromb Haemost 5 (2007) 910-917
12. Gachet C. P2 receptors, platelet function and pharmacological implications. Thromb Haemost 99 (2008) 466-472
13. Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 61 (2004) 498-511
14. 1 cation channel in thrombosis of small arteries in vivo. J Exp Med 198 (2003) 661-667
15. Holmsen H., and Weiss H.J. Secretable storage pools in platelets. Annu Rev Med 30 (1979) 119-134
16. Jackson S.P., and Schoenwaelder S.M. Antiplatelet therapy: in search of the 'magic bullet'. Nat Rev Drug Discov 2 (2003) 775-789
17. Jackson S.P. The growing complexity of platelet aggregation. Blood 109 (2007) 5087-5095
18. Kaczmarek E., Koziak K., Sévigny J., et al. Identification and characterization of CD39 vascular ATP diphosphohydrolase. J Biol Chem 271 (1996) 33116-33122
19. Kim H.H., and Liao J.K. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol 28 (2008) s39-s42
20. Koziak K., Bojakowska M., Robson S.C., et al. Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty. J Thromb Haemost 6 (2008) 1191-1197
21. 1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol 131 (2000) 108-114
22. 1 receptors in platelet activation. Platelets 15 (2004) 131-144
23. Marcus A.J., Broekman M.J., Drosopoulos J.H.F., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99 (1997) 1351-1360
24. Marcus A.J., Broekman M.J., Drosopoulos J.H., et al. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost 1 (2003) 2497-2509
25. Marcus A.J., Broekman M.J., Drosopoulos J.H., et al. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 31 (2005) 234-246
26. 12 antagonism: promises and challenges. Arterioscler Thromb Vasc Biol 28 (2008) s33-s38
27. Nesbitt W.S., Mangin P., Salem H.H., and Jackson S.P. The impact of blood rheology on the molecular and cellular events underlying arterial thrombosis. J Mol Med 84 (2006) 989-995
28. 1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 86 (2001) 1264-1271
29. Pinsky D.J., Broekman M.J., Peschon J.J., et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 109 (2002) 1031-1040
30. Robson S.C., Sévigny J., and Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2 (2006) 409-430
31. Ruggeri Z.M., and Mendolicchio G.L. Adhesion mechanisms in platelet function. Circ Res 100 (2007) 1673-1685
32. Sage S.O., and Rink T.J. The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets. J Biol Chem 262 (1987) 16364-16369
33. 2TAC receptors in ADP-evoked calcium signalling in human platelets. Cell Calcium 28 (2000) 119-126
34. Schwarz U.R., Walter U., and Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 62 (2001) 1153-1161
35. Serebruany V.L., Malinin A.I., Ferguson J.J., et al. Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129 314 patients. Fundam Clin Pharmacol 22 (2008) 315-321
36. Strony J., Beaudoin A., Brands D., and Adelman B. Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol 265 (1993) H1787-H1796
37. Uluckan O., Eagleton M.C., Floyd D.H., et al. APT102, a novel ADPase, cooperates with aspirin to disrupt bone metastasis in mice. J Cell Biochem 104 (2008) 1311-1323
38. 2X receptor for extracellular ATP. Nature 371 (1994) 516-519
39. Varga-Szabo D., Pleines I., and Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28 (2008) 403-412